Adamis Pharma (GB:0A4X)

Adamis Pharma (0A4X) Stock Price & Analysis


0A4X Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$0.10 - $0.60
Previous Close$0.12
Average Volume (3M)4.12K
Market Cap
Enterprise Value$17.26M
Total Cash (Recent Filing)$1.08M
Total Debt (Recent Filing)$342.56K
Price to Earnings (P/E)N/A
May 11, 2023
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
Shares Outstanding166,483,265
10 Day Avg. Volume39,962
30 Day Avg. Volume4,121
Standard Deviation0.67
Financial Highlights & Ratios
Price to Book (P/B)-24.52
Price to Sales (P/S)36.04
Price to Cash Flow (P/CF)N/A
P/FCF Ratio-0.70
Enterprise Value/Market CapN/A
Enterprise Value/Revenue3.56
Enterprise Value/Gross Profit-12.06
Enterprise Value/Ebitda-0.72
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0




What was Adamis Pharma’s price range in the past 12 months?
Adamis Pharma lowest stock price was $0.10 and its highest was $0.60 in the past 12 months.
    What is Adamis Pharma’s market cap?
    Currently, no data Available
    When is Adamis Pharma’s upcoming earnings report date?
    Adamis Pharma’s upcoming earnings report date is May 11, 2023 which is in 40 days.
      How were Adamis Pharma’s earnings last quarter?
      Adamis Pharma released its earnings results on Mar 16, 2023. The company reported -$0.02 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.02.
        Is Adamis Pharma overvalued?
        According to Wall Street analysts Adamis Pharma’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Adamis Pharma pay dividends?
          Adamis Pharma does not currently pay dividends.
          What is Adamis Pharma’s EPS estimate?
          Adamis Pharma’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does Adamis Pharma have?
          Currently, no data Available
          What happened to Adamis Pharma’s price movement after its last earnings report?
          Adamis Pharma reported an EPS of -$0.02 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -11.111%.
            Which hedge fund is a major shareholder of Adamis Pharma?
            Among the largest hedge funds holding Adamis Pharma’s share is Greenlight Capital Inc. It holds Adamis Pharma’s shares valued at N/A.


              Adamis Pharma Stock Smart Score

              This stock does not have enough of the key information we need to rate it accurately. Smart Score is calculated for stocks traded in Nasdaq, NYSE, TSE and LSE with a market cap above $30M and average 3 months trading volume above $30K.
              Learn more about TipRanks Smart Score

              Company Description

              Adamis Pharma

              Adamis Pharmaceuticals Corp. is a biopharmaceutical company, which engages in the discovery, development and sales of pharmaceutical, specialty biopharmaceutical and other drug products. It offers Symjepi product for allergy, respiratory, opioid overdose, and erectile dysfunction (ED), markets. The company was founded in June 2006 and is headquartered in San Diego, CA.


              Forecast EPS vs Actual EPS

              Similar Stocks
              Price & Change
              Elite Pharmaceuticals
              Cumberland Pharmaceuticals
              Item 9 Labs
              Akari Therapeutics

              Popular Stocks

              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis